Product
STP707
Aliases
STP707 Powder for Injection
2 clinical trials
2 indications
Indication
Healthy SubjectsIndication
Solid TumorClinical trial
A Phase 1, Single-Center, Randomized, Dose-Escalation, Sequential Cohort Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Ascending Dose of STP707 Administered Intravenously in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-08-30
Clinical trial
Ph.1, Open-Label, Dose Escalation & Expansion for Safety, Tolerability, PK, & Anti-Tumor Activity of STP707 Administered IV in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy.Status: Active (not recruiting), Estimated PCD: 2024-03-30